HIGHLIGHTS
- who: Xiang Li and collaborators from the Departmente of Health Service and Transfusion Medicine, Beijing, China have published the Article: Decitabine priming increases anti-PD-1 antitumor efficacy by promoting CD8+ progenitor exhausted T_cell expansion in tumor models, in the Journal: (JOURNAL)
- what: The authors show that low-dose combination therapy of decitabine plus anti-PD-1 markedly improved the magnitude and functionality of the clonally expanded progenitor Tex subset and displayed robust antitumor potency. Since the authors focused on CD8+ cells, the authors selected cells in clusters 2, 5, and 7 (a total of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.